The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
Open accessAbstract
BACKGROUND: Typhoid fever is a major global health problem, the control of which is hindered by lack of a suitable animal model in which to study Salmonella Typhi infection. Until 1974, a human challenge model advanced understanding of typhoid and was used in vaccine development. We set out to establish a new human challenge model and ascertain the S. Typhi (Quailes strain) inoculum required for an attack rate of 60%-75% in typhoid-naive volunteers when ingested with sodium bicarbonate solution. METHODS: Groups of healthy consenting adults ingested escalating dose levels of S. Typhi and were closely monitored in an outpatient setting for 2 weeks. Antibiotic treatment was initiated if typhoid diagnosis occurred (temperature ≥38°C sustained ≥12 hours or bacteremia) or at day 14 in those remaining untreated. RESULTS: Two dose levels (10(3) or 10(4) colony-forming units) were required to achieve the primary objective, resulting in attack rates of 55% (11/20) or 65% (13/20), respectively. Challenge was well tolerated; 4 of 40 participants fulfilled prespecified criteria for severe infection. Most diagnoses (87.5%) were confirmed by blood culture, and asymptomatic bacteremia and stool shedding of S. Typhi was also observed. Participants who developed typhoid infection demonstrated serological responses to flagellin and lipopolysaccharide antigens by day 14; however, no anti-Vi antibody responses were detected. CONCLUSIONS: Human challenge with a small inoculum of virulent S. Typhi administered in bicarbonate solution can be performed safely using an ambulant-model design to advance understanding of host-pathogen interactions and immunity. This model should expedite development of diagnostics, vaccines, and therapeutics for typhoid control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Kaplan-Meier plots demonstrating time to diagnostic endpoints including all diagnoses (A), those diagnosed using clinical (B) and microbiological (C) criteria, and time to fever (first temperature ≥38°C; [D]) and to first positive blood culture (E), following challenge at 2 dose levels (103 or 104 colony-forming units [CFU]) of Salmonella Typhi (Quailes strain). Shaded gray area, end of 2-week observation period (all remaining participants started on antibiotic therapy); dotted gray line with circle symbols, participants challenged with 103 CFU; dashed black lines with square symbols, participants challenged with 104 CFU.](https://figures.cochat.ai/paper-figures/c29bee3626744f5dbd22d644a7ed99cc/an-outpatient-ambulant-design-controlled-human-infection-model-using-escalating-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An experimental human S. Typhi challenge model was recently reestablished, presenting a unique opportunity to investigate typhoid pathogenesis in a controlled setting in the natural host [5–7].”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The diagnostic odds ratio: a single indicator of test performance
Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., & Bossuyt, P. M. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00177-x · Cited by 2,261 · cited 1×
“positivity in infection relative to the odds of positivity in the noninfected; 1 indicating that the test does not discriminate between infected and uninfected) [19] and 95% CIs were calculated to assess performance of individual symptoms reported for typhoid diagnosis to be made.”
BackgroundParry, C. M., Hien, T. T., Dougan, G., White, N. J., & Farrar, J. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020201 · Cited by 1,112
Self-citationTyphoid fever: pathogenesis and immunologic control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Dawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009242831306 · Cited by 565
Acid resistance in enteric bacteria
Gorden, J., & Small, P. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.364-367.1993 · Cited by 444 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundWain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Hoa, N. T. T., Parry, C. M., & White, N. J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1683-1687.1998 · Cited by 291 · cited 1×
“We found very low numbers of bacteria to be present in the peripheral blood at the time of clinical diagnosis, a finding supported by field data, albeit in an endemic setting [37].”
BackgroundPathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery
Levine, M. M., DuPont, H. L., Formal, S. B., Hornick, R. B., Takeuchi, A., Gangarosa, E. J., Snyder, M. J., & Libonati, J. P. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/127.3.261 · Cited by 246 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundEvaluation of a UDP-Glucose-4-Epimeraseless Mutant of Salmonella typhi as a Live Oral Vaccine
Gilman, R. H., Hornick, R. B., Woodward, W. E., DuPont, H. L., Snyder, M. J., Levine, M. M., & Libonati, J. P. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.6.717 · Cited by 217
Typhoid Fever: Pathogenesis and Immunologic Control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Hawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197010012831406 · Cited by 184 · cited 1×
“In particular, lower levels of pathogen exposure are thought to more closely replicate natural infection and there is less chance of overwhelming any infection- or vaccinederived protective responses seen, an issue noted previously in typhoid challenge/vaccine studies [10, 22, 23, 25].”
BackgroundThe diagnostic significance of relative bradycardia in infectious disease
Cunha, B. A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.0194f.x · Cited by 135 · cited 1×
“9°C (heart rate <120 bpm) [20].”
UK Standards for Microbiology Investigations
Test, N. (2014) · Cited by 131
Kotloff, K. L., Nataro, J. P., Losonsky, G. A., Wasserman, S. S., Hale, T. L., Taylor, D. N., SADOFF, J. C., & Levine, M. M. (1995) · Vaccine · doi:10.1016/0264-410x(95)00102-7 · Cited by 117 · cited 1×
“In particular, lower levels of pathogen exposure are thought to more closely replicate natural infection and there is less chance of overwhelming any infection- or vaccinederived protective responses seen, an issue noted previously in typhoid challenge/vaccine studies [10, 22, 23, 25].”
BackgroundPasetti, M. F., Levine, M. M., & Sztein, M. B. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00472-3 · Cited by 107
Host– interaction: human trials
Levine, M. M., Tacket, C. O., & Sztein, M. B. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01487-3 · Cited by 107 · cited 3×
“Quailes strain can express the Vi antigen and is fully antibiotic susceptible [2, 5].”
BackgroundInfluentialRefinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
Harro, C. D., Chakraborty, S., Feller, A. J., DeNearing, B., Cage, A., Ram, M., Lundgren, A., Svennerholm, A., Bourgeois, A. L., Walker, R. I., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05194-11 · Cited by 95 · cited 1×
“In particular, lower levels of pathogen exposure are thought to more closely replicate natural infection and there is less chance of overwhelming any infection- or vaccinederived protective responses seen, an issue noted previously in typhoid challenge/vaccine studies [10, 22, 23, 25].”
BackgroundMultidrug-Resistant Typhoid Fever With Neurologic Findings on the Malawi-Mozambique Border
Lutterloh, E. C., Likaka, A. T. M., Sejvar, J. J., Manda, R., Naiene, J. D., Monroe, S. S., Khaila, T., Chilima, B. Z., Mallewa, M., Kampondeni, S., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis012 · Cited by 87 · cited 1×
“This range and severity of symptoms may also be more in keeping with the true early, untreated (both antibiotic, analgesic, and anti-inflammatory) clinical presentation of typhoid infection, however [34, 35], and are more compatible with those noted among ill returning travellers, rather than patients in endemic setti…”
ResultGlynn, J. R., & Bradley, D. J. (1992) · Epidemiology and Infection · doi:10.1017/s0950268800050366 · Cited by 73 · cited 1×
“Interestingly, there was no association between dose and severity of clinical disease or time to onset of symptoms, which was also noted in the Maryland studies [26].”
DuPont, H. L., Hornick, R. B., Weiss, C. F., Snyder, M. J., & Woodward, T. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197001082820201 · Cited by 64 · cited 1×
“Data from this model were directly applied to improve understanding of antibiotic mechanisms [7] and used in vaccine (a first step toward eventual licensure of Ty21a vaccine) [8–10] and diagnostic development [11, 12].”
MethodKhan, M. I., Soofi, S. B., Ochiai, R. L., Khan, M. J., Sahito, S. M., Habib, M. A., Puri, M. K., von Seidlein, L., Park, J. K., You, Y. A., et al. (2012) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1967 · Cited by 61 · cited 1×
“Whereas the range of symptoms reported by participants in our study is in keeping with those from previous Maryland studies and community settings, in general, our participants were more symptomatic throughout the challenge period [28–33].”
ResultLevine, M. M., DuPont, H. L., Hornick, R. B., Snyder, M. J., Woodward, W., Gilman, R. H., & Libonati, J. P. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.4.424 · Cited by 57
Enteric fever in a UK regional infectious diseases unit: A 10 year retrospective review
Clark, T. W., Daneshvar, C., Pareek, M., Perera, N., & Stephenson, I. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.11.009 · Cited by 47 · cited 2×
“ill returning travellers, rather than patients in endemic settings or children [30–33].”
BackgroundResultUnlocking the genome of the human typhoid bacillus
Wain, J. R., House, D., Parkhill, J., Parry, C. M., & Dougan, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00225-6 · Cited by 42 · cited 1×
“This range and severity of symptoms may also be more in keeping with the true early, untreated (both antibiotic, analgesic, and anti-inflammatory) clinical presentation of typhoid infection, however [34, 35], and are more compatible with those noted among ill returning travellers, rather than patients in endemic setti…”
ResultLyon, C. E., Sadigh, K. S., Carmolli, M. P., Harro, C. D., Sheldon, E. A., Lindow, J. C., Larsson, C. J., Martinez, T., Feller, A. J., Ventrone, C. H., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.017 · Cited by 38
Hassing, R., Goessens, W. H. F., Mevius, D. J., van Pelt, W., Mouton, J. W., Verbon, A., & van Genderen, P. J. J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1878-9 · Cited by 37 · cited 2×
“ill returning travellers, rather than patients in endemic settings or children [30–33].”
BackgroundResultGlynn, J. R., Hornick, R. B., Levine, M. M., & Bradley, D. J. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058088 · Cited by 36
Appraisal of typhoid vaccine in experimentally infected human subjects.
Hornick, R. B., & Woodward, T. E. (1967) · PubMed · Cited by 34
Typhoid Fever in an Inner City Hospital: A 5‐Year Retrospective Review
Farmakiotis, D., Varughese, J., Sue, P. K., Andrews, P., Brimmage, M., Dobroszycki, J., & Coyle, C. (2012) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2012.00665.x · Cited by 34 · cited 1×
“There are few previous reports regarding this phenomenon, but these include observations made in returning travelers [36]; although not specific for typhoid fever diagnosis, this finding may be useful in predicting likely outcome in the highly controlled challenge setting.”
BackgroundPradhan, R., Shrestha, U., Gautam, S. C., Thorson, S., Shrestha, K., Yadav, B. K., Kelly, D. F., Adhikari, N., Pollard, A. J., & Murdoch, D. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047531 · Cited by 33 · cited 2×
“ill returning travellers, rather than patients in endemic settings or children [30–33].”
BackgroundResultDuodenal isolation of Salmonella typhi by string capsule in acute typhoid fever
Gilman, R. H., & Hornick, R. B. (1976) · Journal of Clinical Microbiology · doi:10.1128/jcm.3.4.456-457.1976 · Cited by 31 · cited 1×
“Data from this model were directly applied to improve understanding of antibiotic mechanisms [7] and used in vaccine (a first step toward eventual licensure of Ty21a vaccine) [8–10] and diagnostic development [11, 12].”
MethodVolunteer studies of typhoid fever and vaccines
Woodward, W. E. (1980) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(80)90133-9 · Cited by 31 · cited 4×
“(%) 5 (24) 8 (40) 13 (32) Alcohol intake, units, median [IQR] 6 [3–10] 5 [1.”
BackgroundInfluentialTacket, C. O., Losonsky, G. A., Taylor, D. N., Baron, L. S., Kopecko, D. J., Cryz, S. J., & Levine, M. M. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.4.901 · Cited by 31 · cited 1×
“Interestingly, no change in Vi antibody titer was seen in study participants, supporting previous findings from Maryland and those from studies of engineered Vi Ty21a vaccine strains [28, 40].”
ResultDimitrov, T. S., Udo, E. E., Albaksami, O., Al-Shehab, S., Kilani, A., Shehab, M., & Al-Nakkas, A. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46814-0 · Cited by 26 · cited 2×
“ill returning travellers, rather than patients in endemic settings or children [30–33].”
BackgroundResultWhole-Blood Amino Acids in Experimentally Induced Typhoid Fever in Man
Feigin, R. D., Klainer, A. S., Beisel, W. R., & Hornick, R. B. (1968) · New England Journal of Medicine · doi:10.1056/nejm196802082780602 · Cited by 26 · cited 1×
“Data from this model were directly applied to improve understanding of antibiotic mechanisms [7] and used in vaccine (a first step toward eventual licensure of Ty21a vaccine) [8–10] and diagnostic development [11, 12].”
MethodGuidelines for the public health management of typhoid and paratyphoid in England
Balasegaram, S., Potter, A., Grynszpan, D., Barlow, S., Behrens, R. H., Lighton, L., Booth, L., Inamdar, L., Neal, K., Nye, K., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.05.005 · Cited by 25 · cited 1×
“recommendations for contact screening [38].”
Volunteers in Typhoid Infection Study Will Aid Future Vaccine Development
Marwick, C. S. (1998) · JAMA · doi:10.1001/jama.279.18.1423 · Cited by 18 · cited 2×
“Statistical Analyses An initial challenge dose of 10(3) CFU was chosen as the highest dose from the historical studies that did not lead to clinical infection [5, 17, 18].”
BackgroundMethodDoctor T. E. Woodward's Legacy: From Typhus to Typhoid Fever
Hornick, R. B., Woodward, W. E., & Greisman, S. E. (2007) · Clinical Infectious Diseases · doi:10.1086/518138 · Cited by 18
ASYMPTOMATIC TYPHOIDAL BACTEREMIA IN VOLUNTEERS.
Snyder, M. J., Hornick, R. B., McCrumb, F. R., Lj, M., & Woodward, T. E. (1963) · PubMed · Cited by 14
Research works printed but not linked: 4
- Standards Unit, 2013, Investigation of faecal specimens for enteric pathogens
- Standards Unit, 2013, Investigation of blood cultures (for organisms other than Mycobacterium species)
- Standards Unit, 2011, Identification of Salmonella species
- Woodard, 1980, Summary of 1886 subjects in volunteer challenges
Cited by
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-15 · Cited by 1,156
“Recent human challenge studies have also demonstrated that a proportion of patients develop a subclinical or asymptomatic bacteremia and that fecal shedding can occur in the period before symptom development, during primary infection (51).”
BackgroundSalmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever
Dougan, G., & Baker, S. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091313-103739 · Cited by 338
Jin, C., Gibani, M. M., Moore, M., Juel, H. B., Jones, E., Meiring, J., Harris, V., Gardner, J., Nebykova, A., Kerridge, S. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32149-9 · Cited by 313
Self-citationProgress in Typhoid Fever Epidemiology
Crump, J. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy846 · Cited by 186
“Human challenge studies demonstrate that fecal shedding and even bacteremia may occur in the absence of clinical signs of typhoid fever [7].”
BackgroundInflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets
Hitchcock, J. R., Cook, C. N., Bobat, S., Ross, E. A., Flores-Langarica, A., Lowe, K. L., Khan, M., Dominguez-Medina, C. C., Lax, S., Carvalho-Gaspar, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79070 · Cited by 175
“In a recent controlled study of typhoid infection in human volunteers, bacteremia occurred in the majority of cases, but subjects had less than 2 bacteria per ml of blood (45).”
Background
Metadata
- Authors
- Waddington, C. S., Darton, T. C., Jones, C., Haworth, K., Peters, A., John, T., Thompson, B. A. V., Kerridge, S. A., Kingsley, R. A., Zhou, L., Holt, K. E., Yu, L.-M., Lockhart, S., Farrar, J. J., Sztein, M. B., Dougan, G., Angus, B., Levine, M. M., & Pollard, A. J.
- Affiliations
- University of Oxford (GB)
- National Institute for Health and Care Research (GB)
- Wellcome Sanger Institute (GB)
- The University of Melbourne (AU)
- Emergent BioSolutions (United Kingdom) (GB)
- University of Maryland, Baltimore (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-10
- Volume
- 58
- Issue
- 9
- Pages
- 1230-1240
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3982839
- OpenAlex
- W2123106908
- Cited by
- 148
- References
- 37
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 3 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 16 · 2019: 15 · 2018: 11 · 2017: 23 · 2016: 12 · 2015: 14 · 2014: 7
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (100891, 092661)
- National Institute for Health and Care Research (ACF-2007-12-003)
- University of Oxford
- National Institutes of Health
- Centers for Disease Control and Prevention
- NIHR Oxford Biomedical Research Centre
- National Institute of Allergy and Infectious Diseases (R01AI036525, U19AI082655)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Vibrio bacteria research studies
- Keywords
- typhoid fever, Salmonella typhi, human challenge model, controlled human infection model, sodium bicarbonate solution, dose escalation, attack rate, fecal shedding, lipopolysaccharide antigen, Vi antibody
- MeSH terms
- Adolescent, Adult, Ambulatory Care, Antibodies, Bacterial, Female, Humans, Male, Middle Aged, Salmonella typhi, Typhoid Fever, Typhoid-Paratyphoid Vaccines, Bacteremia, Sodium Bicarbonate, Models, Immunological, Host-Pathogen Interactions, Bacterial Shedding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.